International Clinical Trial: SYNCHRONIZE(R)-HERA: A Study to Test Whether Survodutide Helps Women Who Are Living With Overweight or Obesity and Are Going Through or Have Finished Menopause, to Lose Weight

Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (NCT07850050) titled 'SYNCHRONIZE(R)-HERA: A Study to Test Whether Survodutide Helps Women Who Are Living With Overweight or Obesity and Are Going Through or Have Finished Menopause, to Lose Weight' on Sept. 25.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).

Primary Sponsor: Boehringer Ingelheim

Condition: Obesity

Intervention: Combination Product: Survodutide

Recruitment Status: Not recruiting

Phase: Phase 3

Date of First Enrollment: October 31, 2026

Target Sa...